Details for 2019206925
Up to date per 05.04.2026
Actions
Details for 2019206925
Granted/Registered
European Patent
18.03.2020 A
28.09.2022 B1
25.02.2014
US
201461944189 P
10.07.2014
US
201462022916 P
05.09.2014
US
201462046783 P
C07D 401/14 20060101AFI20200115BHEP
Owner
Achillion Pharmaceuticals, Inc.121 Seaport Blvd. Boston, MA 02210US
Representative
Representative
Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT
Inventor
GADHACHANDA, Venkat, Raoc/o Achillion Pharmaceuticals, Inc. 121 Seaport Blvd. Boston, MA 02210,US
WANG, Qiupingc/o Achillion Pharmaceuticals, Inc. 121 Seaport Blvd. Boston, MA 02210,US
PAIS, Godwinc/o Achillion Pharmaceuticals, Inc. 121 Seaport Blvd. Boston, MA 02210,US
HASHIMOTO, Akihiroc/o Achillion Pharmaceuticals, Inc. 121 Seaport Blvd. Boston, MA 02210,US
CHEN, Daweic/o Achillion Pharmaceuticals, Inc. 121 Seaport Blvd. Boston, MA 02210,US
WANG, Xiangzhuc/o Achillion Pharmaceuticals, Inc. 121 Seaport Blvd. Boston, MA 02210,US
AGARWAL, Atulc/o Achillion Pharmaceuticals, Inc. 121 Seaport Blvd. Boston, MA 02210,US
DESHPANDE, Milindc/o Achillion Pharmaceuticals, Inc. 121 Seaport Blvd. Boston, MA 02210,US
WILES, Jason, Allanc/o Achillion Pharmaceuticals, Inc. 121 Seaport Blvd. Boston, MA 02210,US
PHADKE, Avinash, S.c/o Achillion Pharmaceuticals, Inc. 121 Seaport Blvd. Boston, MA 02210,US
Information about Fees